Search

Your search keyword '"Bruno Mégarbane"' showing total 674 results

Search Constraints

Start Over You searched for: Author "Bruno Mégarbane" Remove constraint Author: "Bruno Mégarbane"
674 results on '"Bruno Mégarbane"'

Search Results

151. Temporal Trends of Out-of-Hospital Cardiac Arrests Without Resuscitation Attempt by Emergency Medical Services

152. A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients

153. Clinical Toxicology review metrics and expert reviewers, 2020

154. Persistent brainwave disruption and cognitive impairment induced by acute sarin surrogate sub-lethal dose exposure

155. Recommendations from the EXTRIP workgroup on extracorporeal treatment for baclofen poisoning

156. Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients – A narrative review and hypotheses

157. Molecular adsorbent recirculating system (MARS) and continuous veno-venous hemodiafiltration (CVVHDF) for diltiazem removal: An in vitro study

158. High Prevalence of Fungal Infections in Mechanically Ventilated COVID-19 Patients in the ICU: The French Multicenter MYCOVID Study

159. Relationship between acute kidney injury and mortality in poisoning – a systematic review and metanalysis

160. Comment on: Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial

161. Is Curfew Effective in Limiting SARS-CoV-2 Progression? An Evaluation in France Based on Epidemiokinetic Analyses

162. Marked and prolonged serotonin toxicity in a tramadol-poisoned patient with a pharmacokinetic study

163. Variation of drugs involved in acute drug toxicity presentations based on age and sex: an epidemiological approach based on European emergency departments

164. Intoxication par graines de ricin : intérêt du suivi de la ricinine par Chromatographie Liquide couplée à la Spectrométrie de Masse en Haute Résolution

165. Are sodium nitrite exposures increasing in the United States?

166. Management of Chloroquine and Hydroxychloroquine Poisoning: Do Not Miss the Time of Tracheal Intubation and Mechanical Ventilation

167. Identifying lithium‐poisoned patients who may benefit from haemodialysis remains highly challenging

168. Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

169. Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study

170. Increased anticoagulation reduces proximal deep vein thrombosis in mechanically ventilated COVID-19 patients

171. Immediate coronary angiogram in out-of-hospital cardiac arrest patients with non-shockable initial rhythm and without ST-segment elevation — Is there a clinical benefit?

172. Opioid use disorder in two samples of the Lebanese population: scale validation and correlation with sleep and mood disorders

173. Does MARS™ beneficially affect hemodynamics in refractory vasoplegic shock due to calcium-channel blocker poisoning? Evidence is missing

175. Acute Poisoning with Rhabdomyolysis in the Intensive Care Unit: Risk Factors for Acute Kidney Injury and Renal Replacement Therapy Requirement

176. Ultrasound Guidance and Risk for Central Venous Catheter-Related Infections in the Intensive Care Unit: A Post Hoc Analysis of Individual Data of 3 Multicenter Randomized Trials

177. Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study

178. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients

179. Hydroxychloroquine Overdose: What Are the Exact Roles of Diazepam and Potassium Infusion?

180. Snake venom‐derived bradykinin‐potentiating peptides: A promising therapy for COVID ‐19?

181. Long-Term Disabilities of Survivors of Out-of-Hospital Cardiac Arrest

183. Cluster of chalazia in nurses using eye protection while caring for critically ill patients with COVID-19 in intensive care

184. Do COVID-19 patients admitted to the ICU require anti-Pneumocystis jirovecii prophylaxis?

185. Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19

186. High prevalence of deep vein thrombosis in mechanically ventilated COVID-19 patients

187. Concentration-dependent mortality of chloroquine in overdose

188. Molecular Mechanisms Mediating Adaptation to Exercise

189. High prevalence of putative invasive pulmonary aspergillosis in critically ill COVID-19 patients

190. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?

191. Clinical and Epidemiological Characteristics of Severe Acute Adult Poisoning Cases in Martinique: Implicated Toxic Exposures and Their Outcomes

192. Naloxone should remain the appropriate antidote to treat opioid overdose

193. Low rates of immediate coronary angiography among young adults resuscitated from sudden cardiac arrest

194. Association of systemic secondary brain insults and outcome in patients with convulsive status epilepticus: A post hoc study of a randomized controlled trial

195. One-year outcome of patients admitted after cardiac arrest compared to other causes of ICU admission. An ancillary analysis of the observational prospective and multicentric FROG-ICU study

196. Molecular Mechanisms Mediating Adaptation to Exercise

197. Abdominal pain related to adulterated opium: An emerging issue in drug addicts

198. Outcomes in 886 Critically Ill Patients After Near-Hanging Injury

199. J Hosp Infect

200. Trends in severe opioid-related poisonings and fatalities reported to the Paris poison control center – a 10-year retrospective observational study

Catalog

Books, media, physical & digital resources